Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
40.4M
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
33.5M
-
Shares change
-
-1.22M
-
Total reported value, excl. options
-
$439M
-
Value change
-
-$14.2M
-
Put/Call ratio
-
0.02
-
Number of buys
-
61
-
Number of sells
-
-39
-
Price
-
$13.11
Significant Holders of Pulmonx Corp - COMMON STOCK (LUNG) as of Q2 2023
131 filings reported holding LUNG - Pulmonx Corp - COMMON STOCK as of Q2 2023.
Pulmonx Corp - COMMON STOCK (LUNG) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.5M shares
of 40.4M outstanding shares and own 82.96% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (5.52M shares), Point72 Asset Management, L.P. (3.33M shares), BlackRock Inc. (2.91M shares), VANGUARD GROUP INC (2M shares), MORGAN STANLEY (1.97M shares), FMR LLC (1.63M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.06M shares), BRAIDWELL LP (999K shares), KPCB XIII Associates, LLC (995K shares), and STATE STREET CORP (988K shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.